Search

everythinglearnresearchcommunity

for

Search:↓

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Dermoscopy is useful for diagnosing and monitoring discoid lupus erythematosus by showing specific skin patterns.

Trichoscopy is useful for early detection and monitoring of female pattern hair loss.

Hormone levels can help predict metformin treatment success in women with PCOS.

AI can improve early diagnosis and treatment of diabetic foot complications but requires addressing training and ethical challenges.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

Nanoparticle-based dressings and theranostic innovations improve chronic wound care by effectively targeting biofilms and offering precise treatment.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

HIV-infected men who have sex with men are at higher risk for aggressive syphilis, but treatment and tests are effective.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

New findings suggest certain genes and microRNAs are crucial for wound healing, and innovative technologies like smart bandages and apps show promise in improving treatment.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The new method combining dermoscopy and Reflectance Confocal Microscopy is more effective for evaluating vitiligo.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

The dfRootChip revealed how Arabidopsis roots adapt and grow in uneven conditions.

Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Gefitinib can cause hair and eyebrow darkening.